Примери за използване на Mg of powder на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Mg of powder(corresponding to 10 MIU) in a vial(type I glass), with a stopper(butyl rubber) in a flip-off lp.
Colourless glass vials(type I) with a rubber(butyl) closure and an aluminium flip-off cap,containing 0.56 mg of powder.
Mg of powder in a 10 ml vial(type I glass) with a stopper(butyl rubber) and a flip-off seal(aluminium).
One pack of Carmustine Obvius contains one vial with 100 mg of powder and one ampoule with 3 ml of solvent.
Mg of powder in a vial(Type I glass) with a rubber stopper, an aluminium seal and a plastic flip- off cap.
Type I amber glass vial with chlorobutyl rubber stopper andcrimp seal with flip off cap containing 1 mg of powder.
Mg of powder in a vial(Type I glass) closed with a stopper(butyl rubber) and a flip-off cap(aluminium plastic).
ML, colourless, type I glass vial, closed with chlorobutyl rubber stopper and aluminium crimped capsule(green)containing 5.02 mg of powder.
Mg of powder(corresponding to 3 MIU) in a vial(type I glass), with a stopper(butyl rubber) in a flip-off seal(aluminium) with a bonnet(polypropylene) t.
ML, colourless, type I glass vial, closed with chlorobutyl rubber stopper and crimped aluminium capsule(yellow)containing 2.82 mg of powder.
Mg of powder in a vial(Type 1 glass) with a stopper(siliconised butyl) and a seal(aluminium) with a flip-off cap(plastic).
Synagis is presented as a powder and solvent for solution for injection(100 mg of powder in vial)+ 1 ml of solvent in ampoule- Pack size of 1.
Mg of powder(corresponding to 5 MIU) in a vial(type I glass), with a stopper(butyl rubber) in a flip-off lp.
Benlysta 400 mg powder for concentrate for solution for infusion Type 1 glass vials(20 ml), sealed with a siliconised chlorobutyl rubber stopper anda flip-off aluminum seal containing 400 mg of powder.
One pack contains one vial with 100 mg of powder for concentrate for solution for infusion and one ampoule with 3 ml of solvent.
Mg of powder for solution for infusion in a single-use glass vial(type I), sealed with bromobutyl stopper and aluminium flip-off cap.
Respreeza 4,000 mg powder andsolvent for solution for infusion Respreeza 4,000 mg of powder in a glass vial(type I), closed with a rubber(bromobutyl or chlorobutyl) stopper and an aluminium seal with a plastic flip off cap.
Mg of powder in a vial(Type I glass) with stopper(butyl rubber) covered with a film(fluoropolymer) in the product side and 0.5ml of solvent in an ampoule(Type I glass).
Mg of powder(corresponding to 10 MIU) in a vial(type I glass), with a stopper(butyl rubber) in a flip-off seal(aluminium) with a bonnet(polypropylene) and 1 ml water for injections in an ampoule(type I glass).
Mg of powder(corresponding to 1 MIU) in a vial(type I glass), with a stopper(butyl rubber) in a flip-off seal(aluminium) with a bonnet(polypropylene) and 1 ml water for injections in an ampoule(type I glass) with 1 injection syringe, 2 injection needles and 1 cleansing swab.
Mg of nettle leaf powder.
Mg of rose hip powder per tablet.
Each single-use vial contains 80 mg of degarelix powder as degarelix acetate.
Mg of nettle leaf powder per serving.
Mg of Acai juice powder per dose.
Each sachet contains 500 mg of losartan potassium powder.
SOMAVERT 25 mg: One vial of powder contains 25 mg pegvisomant. After reconstitution with.
Contains 150 mg of brown seaweed(as fucoxanthin), 25 mg of pomegranate powder and 66 mg of calcium.
Kadcyla 160 mg powder for concentrate for solution for infusion One vial of powder for concentrate for solution for infusion contains 160 mg of trastuzumab emtansine.
One capsule contains 83.7 mg of pancreas powder of porcine origin including the following enzymatic activities.